Sandeep Kumar

Sandeep Kumar, Research Scientist, holds a PhD degree in Biochemistry and his academic research work was focused on drug discovery. He authored several research articles, reviews and book chapters in peer reviewed journals. After graduation in 2019, he served as an Assistant Professor of Biochemistry in veterinary research institute in India. In 2020, he joined as a Research Scientist in Clinical Science department of Targovax, a clinical stage immuno-oncology company. He was responsible for planning and execution of preclinical projects on newly constructed adenoviruses. He was also involved in clinical data analysis of Targovax’s lead clinical candidate, ONCOS-102, a genetically modified oncolytic adenovirus. He brings his expertise in preclinical and early-stage clinical drug development to Valo.